Extreme Networks Reports First Quarter Fiscal Year 2026 Financial Results
Q1 revenue up 15% year-over-year, marking sixth consecutive quarter of sequential growth SaaS ARR up 24% YoY MORRISVILLE, N.C.–(BUSINESS WIRE)–Extreme... Read more.
Elucid Launches PlaqueIQ Image Analysis Software for the Carotid Arteries
The first and only CT-based plaque analysis indicated for the carotid anatomy that can help physicians assess risk of rupture and ischemic stroke 1 BOSTON–(BUSINESS... Read more.
Fiserv Announces Transfer of Stock Exchange Listing to Nasdaq
Ticker changing from “FI” to “FISV” MILWAUKEE–(BUSINESS WIRE)–Fiserv, Inc. (NYSE: FI), a leading global provider of payments and financial services... Read more.
Bausch + Lomb Announces Third-Quarter 2025 Results
Revenue of $1.281 Billion GAAP Net Loss Attributable to Bausch + Lomb Corporation of $28 Million Adjusted EBITDA (non-GAAP)1 of $243 Million; Adjusted EBITDA Excluding... Read more.
Magnachip Launches 650V Super Junction TOLL Package Products with Integrated Kelvin Source
– New Package Lineup Targets Premium Consumer Electronics and High-Power/High-Current Markets – Additional SJ MOSFET TOLL products are planned to be... Read more.
RYI Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of Ryerson Holding Corporation is Fair to Shareholders
Shareholders should contact the firm immediately as there may be limited time to enforce your rights NEW YORK–(BUSINESS WIRE)–Halper Sadeh LLC, an investor... Read more.
Materion Corporation Reports Strong Third Quarter 2025 Financial Results and Affirms Full Year Outlook
MAYFIELD HEIGHTS, Ohio–(BUSINESS WIRE)–Materion Corporation (NYSE: MTRN) today reported third-quarter 2025 financial results and affirmed full year outlook.... Read more.
European Commission Approves KEYTRUDA® (pembrolizumab) as Part of a Treatment Regimen for Adults with Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC) Expressing PD-L1 (CPS >1)
KEYTRUDA monotherapy now approved as neoadjuvant treatment, continued as adjuvant treatment combined with radiotherapy with or without concomitant cisplatin then... Read more.
Evercore Reports Third Quarter 2025 Results; Quarterly Dividend of $0.84 Per Share
NEW YORK–(BUSINESS WIRE)–Evercore Inc. (NYSE: EVR): Third Quarter Results Year to Date Results U.S. GAAP Adjusted U.S. GAAP Adjusted... Read more.
Valero Energy Corporation Announces CFO Transition
Jason Fraser to Retire as CFO December 31 Homer Bhullar to Assume CFO Position SAN ANTONIO–(BUSINESS WIRE)–Valero Energy Corporation (NYSE: VLO, “Valero”)... Read more.